A lthough repetitive brief episodes of ischemia and reperfusion render the myocardium more tolerant against subsequent sustained ischemia and reperfusion, a phenomenon termed "ischemic preconditioning," the effect is believed to be transient, lasting less than 3 hours.1 However, myocardium stimulated with endotoxin2 or interleukin-13 has exhibited resistance to ischemia/reperfusion injury 24-36 hours after stimulation. This tolerance is associated with an increase in the activity of myocardial catalase, an antioxidant enzyme. Endotoxin and interleukin-1 cause free radical generation. Induction of superoxide dismutase (SOD), another antioxidant enzyme, has also been demonstrated under various conditions associated with the production of free radicals such as the superoxide anion. 45 Brief, repeated ischemia induces a series of biochemical stimuli and, with repeated reperfusion, causes free radical generation. This could lead to changes in myocardial antioxidant enzyme activity. In fact, we recently reported that mitochondrial Mn-SOD activity, but not CuZn-SOD or glutathione-related enzyme activity, was significantly increased in ischemic myocardium 24 hours after brief, repeated ischemia. 6 Moreover, ischemia per se and repetitive brief episodes of ischemia and reperfusion are reported to induce heat-shock proteins in the myocardium.7-9 Hyperther-mia induces synthesis of these proteins,10'11 and the heat-shock response has been shown to result in protection against the oxidative stress of myocardial ischemia and reperfusion. '12,3 The aim of this study was to define the delayed effects of repetitive brief ischemia on the size of infarcts induced by sustained ischemia and subsequent reperfusion.
Materials and Methods

Experimental Protocol
Adult mongrel dogs of both sexes (12) (13) (14) (15) kg, n= 125) were anesthetized with pentobarbital sodium (30 mg/kg i.v.), intubated with a cuffed endotracheal tube, and artificially ventilated. An aseptic surgical technique was used in each experiment. A left thoracotomy was performed at the fifth intercostal space, and the heart was suspended in a pericardial cradle. The left anterior descending coronary artery (LAD) was isolated distal to the first major diagonal branch, and an occlusive snare was placed around it. The experimental design is shown in Figure 1 .
The 1 . Experimental design. Preconditioned dogs underwent four 5-minute left anterior descending coronary artery (LAD) occlusions, each separated by 5 minutes of reperfusion (R-1-R-4), followed by a sustained 90-minute occlusion at 0 (n=14), 3 (n=15), 12 (n=17), or 24 (n=17) hours after the sublethal ischemia. Sham-operated control dogs underwent a single 90-minute occlusion at 0 (n=17), 3 (n=15), 12 (n=14), or 24 (n=16) hours after thoracotomy. All dogs were allowed 5 hours of reperfusion after the 90-minute occlusion.
the chest was reopened. Sustained LAD occlusion was then initiated. Blood pressure and heart rate were measured with a catheter inserted into the left carotid artery. Ventilatory settings were adjusted on the basis of arterial blood gas determinations to maintain normal pH and satisfactory oxygenation. The left jugular vein was cannulated for infusion of dye. A catheter was also inserted through the left atrial appendage into the left atrium for administration of colored microspheres. Data on hemodynamic parameters were obtained before and 90 minutes after the coronary occlusion and at 1, 3, and 5 hours after reperfusion. In the preconditioned dogs of the 0-hour and 3-hour groups, the data were also obtained at baseline and at the end of the preconditioning sequences. Experimental animals were excluded from data analysis according to the following criteria: 1) failure to manifest epicardial cyanosis and akinesia in the LAD-perfusing region after occlusion of the coronary artery and 2) intractable ventricular fibrillation requiring more than two attempts at defibrillation with low-energy direct-current (20-J) pulses applied directly to the surface of the heart. The incidence of lack of cyanosis and akinesia and the incidence of lethal arrhythmias are shown in Table 1 . Infarct size was determined in each group (n= [12] [13] [14] and in the respective sham-operated control group (n 12-14).
Quantification of Infarct Size
Infarct size was quantitated by a dual-staining method described previously.14 Briefly, Evans blue dye was injected into the jugular vein while the cannulated LAD was perfused with autologous blood. The dogs were killed, and their hearts were removed and divided into six transverse slices of approximately equal thickness. After incubation in triphenyltetrazolium chloride solution, the infarcted area remained colorless. The percent of myocardium at risk that was infarcted was calculated and used as an index of infarct size.
Measurement of Regional Myocardial Blood Flow
Blood flow measurements were made with 11.9+1.9
gum of colored microspheres (E-Z Trac, Los Angeles) by using the reference withdrawal method.15 Approximately 5 million microspheres labeled with red and black were injected into the left atrium in random order, followed by a 10-ml saline flush. Reference blood was withdrawn at a constant rate (10 ml/min) from the carotid artery starting 10 seconds before the injection and continuing until 50 seconds after the injection (total collection time, 60 seconds). Myocardial blood flow was measured before occlusion and midway through the sustained occlusion. After risk region and infarct size were assessed at the conclusion of the experiment, transmural slabs were cut from the ischemic and nonischemic regions of midventricular slices. Each slab was 
Results
Hemodynamics
Serial changes in the mean arterial blood pressure, heart rate, and rate-pressure products are shown in Table 2 . The data are presented before the sustained application of LAD occlusion, at the end of the 90-minute occlusion, and after 1, 3, and 5 hours of reperfusion. In the preconditioned dogs of the 0-hour and 3-hour groups, the data are also presented at baseline and at the end of the preconditioning sequences. A significant decrease in mean arterial blood pressure was noted in some groups after reperfusion. There was no difference in mean values between experimental and control groups at any time point. Heart rate and mean arterial blood pressure were similar among the groups. Infarct Size The effect of the time interval from preconditioning to induction of sustained ischemia on infarct size is shown in Figure 2 . Data from two to four dogs in each group having subendocardial blood flows greater than 0.15 ml * min-m * g`during the sustained occlusion were excluded from analysis. The final number of dogs analyzed in each group was 10. Infarct size, expressed as a percentage of the anatomic area at risk, was reduced significantly (p<0.01) in preconditioned dogs (14.4+2.0%) compared with the control dogs (39.0±3.7%) when sustained ischemia immediately followed preconditioning. Infarct size was not significantly different between the pretreated and sham-operated dogs when sustained occlusion was accomplished 3 hours (31.2±3.7% versus 37.5±4.2%) or 12 hours (25.4±4.8% versus 35.0±5.3%) after repetitive brief ischemia. However, infarct size in the pretreated dogs (18.8±3.4%) was significantly smaller than in the control dogs (35.1±4.6%, p<0.05) when sustained occlusion was induced 24 hours after repetitive brief ischemia. The infarct-limiting effect of repetitive brief ischemia was slightly less in the 24-hour group than in the 0-hour group.
Anatomic area at risk as a percentage of the left ventricle was not significantly different between the pretreated and sham-operated dogs (Figure 3 ).
Regional Myocardial Blood Flow
We determined whether differences in regional myocardial blood flow could account for the infarct-limiting effect of preconditioning. Regional myocardial blood flow was evaluated before occlusion (baseline) and midway through the sustained occlusion (45 minutes after occlusion of the LAD) ( Table 3) . In all groups, regional myocardial blood flow was not significantly altered in either the subendocardial or subepicardial layer of the nonischemic region. The mean subendocardial blood flow in the LAD-perfused region was significantly reduced to less than 1io of the baseline value during the sustained ischemic period. There were no differences in the regional myocardial blood flow of the subendocardial ischemic region between the preconditioned and control dogs in any of the four paradigms used.
The relation between infarct size and regional myocardial blood flow of the subendocardium during the sustained ischemic period in the LAD-perfused region is shown in Figure 4 . In the 3-hour group, linear regression analysis demonstrated a similar dependence of infarct size on ischemic blood flow in preconditioned and control dogs. However, in the 24-hour group, although the slope of the regression line was similar to that of the control dogs, the absolute infarct size at any given regional myocardial blood flow was reduced (p<O.Ol, by ANCOVA). Although not shown, regression analysis of this relation in the 0-hour group was also significantly different between pretreated and control dogs. These findings indicate that differences in regional myocardial blood flow alone cannot account for the limitation of infarct size by sublethal ischemic preconditioning. Discussion This study demonstrated a delayed effect of repetitive brief ischemia on limiting the size of infarcts induced by sustained LAD occlusion followed by reperfusion. When sustained ischemia immediately followed preconditioning, the infarct-limiting effect of sublethal ischemia was significant. Although there was no difference in infarct size between the pretreated and sham-operated dogs when sustained ischemia was induced 3 or 12 hours after repetitive brief ischemia, a significant effect of preconditioning on infarct size was again seen when sustained ischemia followed repetitive brief ischemia 24 hours later. No differences were seen in regional myocardial blood flow evaluated by colored microspheres or in rate-pressure products during the course of the experiment between the preconditioned and sham-operated groups. These results indicate that the infarctlimiting effects of repetitive brief ischemia can be observed when sustained ischemia immediately follows sublethal ischemic preconditioning or is induced 24 hours later.
The extent of myocardial infarction resulting from sustained LAD occlusion followed by reperfusion was significantly reduced by immediate pretreatment with repetitive brief ischemia. This effect of ischemic preconditioning varies from another report that showed no significant reduction of infarct size when sustained ischemia persisted for 90 minutes followed by reperfusion. 16 The number of preconditioning episodes of ischemia/reperfusion and species difference may ac- It is a new finding, as far as we know, that a significant effect of preconditioning reappeared when sustained LAD occlusion was initiated 24 hours after sublethal ischemia. Although the mechanism for this delayed protection is currently unknown, one possible mechanism is that repetitive brief ischemia may induce the synthesis of a protein, which would then protect the myocardium during sustained ischemia and reperfusion. Such a protein could be an antioxidant enzyme such as catalase or SOD or a heat-shock protein. Recently, we measured the activity of antioxidant enzymes such as SOD and glutathione-related enzymes in the subendocardial and subepicardial sides of the myocardium after repetitive brief ischemia and found a significant increase in Mn-SOD activity of the subendocardial ischemic myocardium 24 hours after sublethal ischemia. 6 Resistance to ischemia/reperfusion injury [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] hours after stimulation with chemical mediators such as endotoxin2 and interleukin-13 is reported to be associated with an increase in the activity of myocardial catalase. In our preliminary study, however, we found no difference in catalase activity between nonischemic and ischemic myocardium 24 hours after sublethal ischemia (authors' unpublished observation). These mediators are known to generate free radicals via an inflammatory response. Exposure to x-radiation4 and treatment with tumor necrosis factor,5 which also induce free radical generation, are reported to enhance SOD activity. In fact, Wong and Goeddel24 have shown that treatment with tumor necrosis factor induces the expression of mRNA for Mn-SOD but not for other antioxidant enzymes such as CuZn-SOD, catalase, or glutathione peroxidase. Pretreatment of cells with low doses of tumor necrosis factor confers resistance to typically lethal higher doses through the overexpression of Mn-SOD. 25 Repetitive brief ischemia generating free radicals during repeated reperfusion phases can induce the synthesis of heat-shock proteins9 and Mn-SOD protein. 6 We have reported previously that no differences were seen in myocardial activities of CuZn-SOD, glutathione peroxidase, or glutathione reductase between the nonischemic and ischemic regions. 6 The increase in Mn-SOD should play a significant role in infarct modification at 24 hours after preconditioning, because the activity of Mn-SOD, CuZn-SOD, and glutathione-related enzymes was not elevated at 3 hours after preconditioning and the content of Mn-SOD was not significantly elevated at 12 hours after preconditioning,6 when no differences were observed in infarct size between the preconditioning and sham-operated control dogs in this study. Myocardial protection against the oxidative stress of ischemia and reperfusion can also be obtained under conditions that induce the heat-shock response.12,'3 We did not examine whether heat-shock proteins are induced in the myocardium with the preconditioning regimen outlined.
Since Thornton et a126 reported that inhibition of protein synthesis by administration of cycloheximide and actinomycin D does not block the early effect of brief ischemia on limiting infarct size, we also examined the effects of these agents on infarct size after sustained LAD occlusion initiated 24 hours after preconditioning. However, no dogs pretreated with these agents survived for 24 hours (n = 3 each) when we used the same doses outlined by Thornton et al. In summary, infarct size was significantly reduced in dogs pretreated with repetitive brief ischemia when sustained ischemia was initiated immediately or 24 hours later but not 3 or 12 hours after sublethal ischemia. The immediate and delayed preconditioning effects on limiting infarct size would be distinct phenomena, with similar effects induced by a different mechanism, since an apparent discrepancy between findings of acute infarct modification (not attributable to protein synthesis) and injury reduction 24 hours after brief ischemia (probably attributable to protein synthesis) was observed. There remain many questions with regard to the delayed effect on limiting infarct size: What is the cardioprotective protein(s)? Is a single episode of brief ischemia enough to cause the same effect? How long does the infarct-limiting effect persist after preconditioning? Is the delayed effect of limiting infarct size different among species? In the clinical setting, the extent of myocardial necrosis in acute infarction may be different in patients with and without preceding anginal episodes despite no difference in the extent of collateral flow or hemodynamic parameters. This is in accordance with the findings from the animal model presented here. Further investigation into the questions posed above will broaden the understanding of cardioprotective preconditioning and may have an impact on the management of acute myocardial infarction and reperfusion injury.
